Can we use a lower dose of liposomal amphotericin B for the treatment of mucosal American leishmaniasis?
about
Treatment of American tegumentary leishmaniasis in special populations: a summary of evidence.Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).Reactivation of mucosal and cutaneous leishmaniasis in a renal transplanted patient.An update on pharmacotherapy for leishmaniasisLeishmaniasis in the United States: treatment in 2012Efficacy and Safety of Liposomal Amphotericin B for the Treatment of Mucosal Leishmaniasis from the New World: A Retrospective StudyLiposomal amphotericin B as a treatment for human leishmaniasisTherapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.Parasitic diseases in travelers: a focus on therapy.LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014.Mucosal leishmaniasis mimicking T-cell lymphoma in a patient receiving monoclonal antibody against TNFα.Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients.Reactivation of cutaneous and mucocutaneous tegumentary leishmaniasis in rheumatoid arthritis patients: an emerging problem?Treatment of mucosal leishmaniasis with amphotericin B lipid complex (ABLC)
P2860
Q27022964-FE281B3E-5FD6-4846-A00A-947D84C0CBF9Q30275257-2F3F8522-DDBF-4B58-B112-563BEEB3D0CAQ33841162-C79514FC-0347-4973-9356-574B7ACB858DQ34945204-E305D6D9-AFB5-43D2-9DF8-B1BBECE978D3Q35771790-0122E0CF-3802-43BD-B03E-41C47329C9F5Q36359258-4802AF87-89AC-47A2-9211-F6C97D0BA516Q36456032-A2CE4F10-64FC-4EF0-B827-9FCC62B86546Q38156421-74FDBFE3-D4E5-494D-88F2-CC9B71AD3EFEQ38192001-24D0BBEF-D54A-4FC6-94E6-2F74EAD2B346Q38205451-DA22FA71-DA37-4C52-8D04-333FA69E891AQ41995657-A231864F-B466-4CFC-A051-2DE83C7644CDQ42228007-AFF6E14C-B794-4EE2-97EE-E57BA4D065D8Q42347671-362A7C18-6336-47F6-903B-4111319D227AQ59139032-52735D4A-590D-4248-B205-3A45264588A2
P2860
Can we use a lower dose of liposomal amphotericin B for the treatment of mucosal American leishmaniasis?
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Can we use a lower dose of lip ...... ucosal American leishmaniasis?
@ast
Can we use a lower dose of lip ...... ucosal American leishmaniasis?
@en
type
label
Can we use a lower dose of lip ...... ucosal American leishmaniasis?
@ast
Can we use a lower dose of lip ...... ucosal American leishmaniasis?
@en
prefLabel
Can we use a lower dose of lip ...... ucosal American leishmaniasis?
@ast
Can we use a lower dose of lip ...... ucosal American leishmaniasis?
@en
P2093
P2860
P1476
Can we use a lower dose of lip ...... ucosal American leishmaniasis?
@en
P2093
Antonio C Nicodemo
Carolina R Santos
Raphael A Camargo
Regina M Souza
Valdir S Amato
P2860
P304
P356
10.4269/AJTMH.2011.11-0287
P407
P577
2011-11-01T00:00:00Z